580 related articles for article (PubMed ID: 1862693)
61. Effect of LDL+VLDL oxidizability and hyperglycemia on blood cholesterol, phospholipid and triglyceride levels in type-I diabetic patients.
Jain SK; McVie R; Meachum ZD; Smith T
Atherosclerosis; 2000 Mar; 149(1):69-73. PubMed ID: 10704616
[TBL] [Abstract][Full Text] [Related]
62. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control.
Pérez A; Caixàs A; Carreras G; Mauricio D; Pou JM; Serrat J; Gómez-Gerique J; de Leiva A
Diabetes Res Clin Pract; 1997 May; 36(2):83-90. PubMed ID: 9229192
[TBL] [Abstract][Full Text] [Related]
63. Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus.
Umeda F; Watanabe J; Inoue K; Hisatomi A; Mimura K; Yamauchi T; Sako Y; Kunisaki M; Tajiri Y; Nawata H
Endocrinol Jpn; 1992 Feb; 39(1):45-50. PubMed ID: 1535040
[TBL] [Abstract][Full Text] [Related]
64. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects.
Laakso M; Pyörälä K; Voutilainen E; Marniemi J
Am J Epidemiol; 1987 Apr; 125(4):611-21. PubMed ID: 3548333
[TBL] [Abstract][Full Text] [Related]
65. The effects of a high-carbohydrate low-fat cholesterol-restricted diet on plasma lipid, lipoprotein, and apoprotein concentrations in insulin-dependent (type I) diabetes mellitus.
Hollenbeck CB; Connor WE; Riddle MC; Alaupovic P; Leklem JE
Metabolism; 1985 Jun; 34(6):559-66. PubMed ID: 3999978
[TBL] [Abstract][Full Text] [Related]
66. Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films.
Marcel YL; Weech PK; Nguyen TD; Milne RW; McConathy WJ
Eur J Biochem; 1984 Sep; 143(3):467-76. PubMed ID: 6479161
[TBL] [Abstract][Full Text] [Related]
67. Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients.
Aslan I; Kucuksayan E; Aslan M
Lipids Health Dis; 2013 Apr; 12():54. PubMed ID: 23617853
[TBL] [Abstract][Full Text] [Related]
68. The effects of nomegestrol acetate subdermal implant (Uniplant) on carbohydrate metabolism, serum lipoproteins and on hepatic function in women.
Barbosa I; Coutinho E; Athayde C; Ladipo O; Olsson SE; Ulmsten U
Contraception; 1995 Aug; 52(2):111-4. PubMed ID: 8536447
[TBL] [Abstract][Full Text] [Related]
69. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.
Taniguchi A; Fukushima M; Sakai M; Miwa K; Makita T; Nagata I; Nagasaka S; Doi K; Okumura T; Fukuda A; Kishimoto H; Fukuda T; Nakaishi S; Tokuyama K; Nakai Y
Diabetes Care; 2000 Dec; 23(12):1766-9. PubMed ID: 11128349
[TBL] [Abstract][Full Text] [Related]
70. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
[TBL] [Abstract][Full Text] [Related]
71. Association of waist circumference with ApoB to ApoAI ratio in black and white Americans.
Okosun IS; Prewitt TE; Liao Y; Cooper RS
Int J Obes Relat Metab Disord; 1999 May; 23(5):498-504. PubMed ID: 10375053
[TBL] [Abstract][Full Text] [Related]
72. [Effect of metabolic control on plasma lipids and lipoproteins in insulin-dependent diabetes in children and adolescents].
Jos J; Thévenin M; Dumont G; Beyne P
Diabete Metab; 1985 Jun; 11(3):174-80. PubMed ID: 3928411
[TBL] [Abstract][Full Text] [Related]
73. Lecithin:cholesterol acyltransferase activity and high-density lipoprotein subfraction composition in type 1 diabetic patients with improving metabolic control.
Weight MJ; Coetzee HS; Smuts CM; Marais MP; Maritz JS; Hough FS; Benadé AJ; Taljaard JJ
Acta Diabetol; 1993; 30(3):159-65. PubMed ID: 8111077
[TBL] [Abstract][Full Text] [Related]
74. Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.
Groop PH; Elliott T; Ekstrand A; Franssila-Kallunki A; Friedman R; Viberti GC; Taskinen MR
Diabetes; 1996 Jul; 45(7):974-9. PubMed ID: 8666151
[TBL] [Abstract][Full Text] [Related]
75. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.
Julier K; Mackness MI; Dean JD; Durrington PN
Diabet Med; 1999 May; 16(5):415-23. PubMed ID: 10342342
[TBL] [Abstract][Full Text] [Related]
76. Lipoproteins and apolipoproteins in young male survivors of myocardial infarction.
Al-Muhtaseb N; Hayat N; Al-Khafaji M
Atherosclerosis; 1989 Jun; 77(2-3):131-8. PubMed ID: 2751745
[TBL] [Abstract][Full Text] [Related]
77. Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics.
Laakso M; Voutilainen E; Sarlund H; Aro A; Pyörälä K; Penttilä I
Atherosclerosis; 1985 Sep; 56(3):271-81. PubMed ID: 3902037
[TBL] [Abstract][Full Text] [Related]
78. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
Rudberg S; Persson B
Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
[TBL] [Abstract][Full Text] [Related]
79. The effects of gender and type of diabetes on HDL-cholesterol.
Merrin PK; Baynes C; Henderson A; Richmond B; Elkeles R
Diabete Metab; 1994; 20(1):20-4. PubMed ID: 8056130
[TBL] [Abstract][Full Text] [Related]
80. Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes.
Taskinen MR; Kuusi T; Helve E; Nikkilä EA; Yki-Järvinen H
Arteriosclerosis; 1988; 8(2):168-77. PubMed ID: 3279941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
